From the desk of Dr. Lewis Blevins comes a review of three important studies on Cushing’s Syndrome: Paediatric Cushing syndrome: a prospective, multisite, observational cohort study – The authors of this study report the largest
Cushing’s
Cushing’s syndrome is a disorder that occurs when your body makes too much of the hormone cortisol over a long period of time. Cortisol is sometimes called the “stress hormone” because it helps your body respond to stress.
A nice idea for a Cushing’s educational resource
Recordati Rare Diseases, a company dedicated to creating needed therapies for extremely rare and devastating diseases, had an excellent idea of approaching their new educational resource website for Cushing’s disease; they asked patients with Cushing’s
Cortisol levels after Cushing’s surgery
An informal discussion of Cushing’s disease issues from cases, articles, and experiences with patients.
A talk with Crinetics Chairman Scott Struthers, Ph.D.
During these trying times, work continues, even at a faster pace, for new drugs and therapies for pituitary patients. From the J D Faccinetti, co-founder – We recently caught up with Crinetics Pharmaceuticals chairman Dr.
Alternative Cushing’s syndrome treatment
Grzegorz Rosiak, M.D., an interventional radiologist from Warsaw Medical University, sends us a recently published article, “Percutaneous Adrenal Gland Thermal Ablation,” an alternative Cushing syndrome treatment. You can read more about thermal ablation of the adrenal gland
Podcast: A conversation with Dr. Maria Fleseriu
With new advances in the Cushings space, we asked Dr. Maria Fleseriu, Professor of Medicine and Neurological Surgery and Director of the Pituitary Center at Oregon Health and Science University in Portland, Oregon, USA, to give us
More information on Recordati’s new Cushing’s drug Isturisa
In a recent press release, Recordati Rare Diseases announced the results from a Phase III study of Isturisa® (Osilodrostat) published in Lancet Diabetes and Endocrinology. “The exciting data, published today, underscore the efficacy and safety
Doctors’ Response to June News Linking Cortisol Level to Death Risk with COVID-19
From Leslie Edwin, President of CSRF and PWN Contributor – On June 18, 2020, online medical journal The Lancet Diabetes and Endocrinology published a report about the association between high cortisol and death rate with COVID-19.
The complex diagnosis of Cushing’s syndrome
In this engaging podcast about the diagnosis of Cushing’s syndrome, Pituitary Worlds News co-founder and Medical Director, California Center for Pituitary Disorders at UCSF Professor of Clinical Medicine and Clinical Neurological Surgery, Dr. Lewis Blevins
From the European Society of Endocrinology: Cushing’s syndrome clinical management guidance during the COVID-19 Pandemic
This is a series of urgent clinical guidance documents on the management of endocrine conditions in the time of COVID-19. This clinical guidance document underwent expedited open peer review by Jérôme Bertherat (Paris, France), André
A new drug for Cushing’s: Learn more
In this podcast, Dr. Lewis Blevins discusses a new drug for Cushing’s disease recently approved in the US.
Critical COVID-19 information for pituitary patients
We caught up with Dr. Kevin Yuen, medical director of the Barrow Pituitary Center and the Barrow Neuroendocrinology Clinic in Phoenix, Arizona, and Dr. Lewis Blevins Medical Director of the California Center for Pituitary Disorders at
From our friends at the Pacific Neuroscience Institute: Cushing’s 101
This article on Cushing’s disease provides a concise, excellent overview of the optimal management and highlights of both surgical and medical advances. Click here to read the article. There are also helpful links to resources